In regards to Da Silva Franca et al.: "localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy" (Brachytherapy 2010; 9(4): 307-312).

Abstract

Patients 72 24 Age (y) 66 (46e84) 68 (58e75) 0.774 95% CI: 64.1e68.8 62.5e73.5 iPSA (ng/mL) 8.8 (3.5e23) 9.9 (3.6e24) 0.419 95% CI: 7.5e10.1 9e15.8 PSAn (ng/mL) 0.36 (0.01e1.88) 0.25 (0.01e1.32) 0.096 95% CI: 0.23e0.50 0.13e0.62 Gleason score 2e6 62 (86%) 10 (42%) 0.001 7e9 19 (14%) 14 (58%) Clinical stage T1ceT2a 7 (9.7%) 2 (8.3%) 0.840 T2beT2c 65 (90.3) 22 (91.7%) Neoadjuvant hormone therapy Yes 36 (50%) 14 (58%) 0.479 No 36 (50%) 10 (42%) 526 Letters to the Editor / Brachytherapy 13 (2014) 522e528

DOI: 10.1016/j.brachy.2014.05.004

1 Figure or Table

Cite this paper

@article{Patil2014InRT, title={In regards to Da Silva Franca et al.: "localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy" (Brachytherapy 2010; 9(4): 307-312).}, author={Nikhilesh G Patil and David D'souza}, journal={Brachytherapy}, year={2014}, volume={13 5}, pages={526-7} }